Denali Therapeutics (DNLI.O) Investment Opportunity 2b期LUMA试验未达标，但Denali的TfRPlatform推动CNS生物制剂Prospect; Target Pricelowered至35USD Please enable JavaScript to view full opportunity details. Back to Recommendations View Reports